Skip to content

Survey study, 2026

What causes PMS and how can we treat it?

This is a review summarizing what is known about PMS. GABA and neurosteroid changes are suspected causes. Both medication and non-medication treatments exist and should be individually chosen.

Early or limited evidence Women of reproductive age (review article, not a study)

What they did

This is a review article summarizing published reports on PMS causes and therapeutic approaches, including both pharmacological (medication) and non-pharmacological (non-medication) interventions.

What they found

Global prevalence of PMS is estimated at around 47%, with 3% to 8% of women significantly affected in daily functioning. Changes in GABA conductance and neurosteroid levels, particularly a chemical called allopregnanolone, are suspected to play a role in PMS.

What it means for you

This article summarizes existing knowledge about PMS rather than presenting new research. It emphasizes that PMS treatment should be individually selected. The abstract does not provide specific treatment recommendations or compare different approaches.

47%

Global prevalence of PMS

3-8%

Percentage severely affected in daily functioning

About the study

Original title
ETHNIC HERBAL MEDICINE IN THE TREATMENT OF PREMENSTRUAL SYNDROME: ETIOLOGY, CLINICAL MANIFESTATIONS AND OTHER MEDICAL INTERVENTIONS
Journal
International Journal of Biology Pharmacy and Allied Sciences
Year
2026
Study design
Survey study
What was tested
None, review article
Open access
Yes

Topics